Last updated on November 2018

A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)


Brief description of study

M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Clinical Study Identifier: NCT02975336

Contact Investigators or Research Sites near you

Start Over

Jose Luis Alfaro Lozano

ICCV Research Instituto del Cerebro y la Columna Vertebral
Miraflores, Peru
1.8miles
  Connect »

Roberto Miguel Huamanchumo Guzman

Clinica Medica Cayetano Heredia
Lima, Peru
2.73miles
  Connect »

Arquimedes Hidalgo Garcia

Clinica Vesalio
Lima, Peru
2.73miles
  Connect »

Julia Elena Calderon Gallegos

GINOBS SA. Instituto de Ginecologia y Reproduccion
Lima, Peru
2.73miles
  Connect »

Mijahil Pavel Cornejo Ortega

Clinica El Golf
Lima, Peru
2.73miles
  Connect »

Armando Calvo Quiroz

Hospital Nacional Cayetano Heredia
Lima, Peru
2.73miles
  Connect »

Kwanghoon Han

University of Washington Medical Center
Lima, Peru
2.73miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.